MedTrace Logo

Screening Protocol for Children and Adolescents With Attention Deficit Hyperactivity Disorder

NCT00592436 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 663

Last updated 2015-05-06

No results posted yet for this study

Summary

The objective of this protocol is to establish a comprehensive screening process to evaluate the eligibility of potential pediatric subjects for appropriate ADHD clinical research studies.

Conditions

  • Pediatric ADHD

Sponsors & Collaborators

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Joseph Biederman, MD · Massachusetts General Hospital

Eligibility

Min Age
6 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-03-31
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00592436 on ClinicalTrials.gov